Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
0.6753
-0.0042 (-0.62%)
At close: Jun 27, 2025, 4:00 PM
0.6870
+0.0117 (1.73%)
After-hours: Jun 27, 2025, 7:42 PM EDT
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $34.97 million as of June 27, 2025. Its market cap has decreased by -10.63% in one year.
Market Cap
34.97M
Enterprise Value
-46.24M
1-Year Change
-10.63%
Ranking
Category
Stock Price
$0.68
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $34.97M, a decrease of -91.81%. That is a compound annual growth rate of -49.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 35.19M | -19.41% |
| Dec 31, 2024 | 43.66M | 188.36% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 215.99B |